Free Trial

AIGH Capital Management LLC Sells 700,000 Shares of Theratechnologies Inc. (NASDAQ:THTX)

Theratechnologies logo with Medical background

AIGH Capital Management LLC cut its holdings in shares of Theratechnologies Inc. (NASDAQ:THTX - Free Report) by 23.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,326,569 shares of the company's stock after selling 700,000 shares during the quarter. Theratechnologies accounts for approximately 1.3% of AIGH Capital Management LLC's holdings, making the stock its 23rd biggest holding. AIGH Capital Management LLC owned approximately 5.06% of Theratechnologies worth $3,257,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in THTX. Raymond James Financial Inc. bought a new stake in Theratechnologies in the fourth quarter valued at $27,000. Bank of America Corp DE boosted its holdings in Theratechnologies by 1,416.7% in the fourth quarter. Bank of America Corp DE now owns 16,487 shares of the company's stock valued at $30,000 after acquiring an additional 15,400 shares in the last quarter. JPMorgan Chase & Co. bought a new stake in Theratechnologies in the fourth quarter valued at $33,000. BNP Paribas Financial Markets bought a new stake in Theratechnologies in the fourth quarter valued at $36,000. Finally, Virtu Financial LLC bought a new stake in Theratechnologies in the fourth quarter valued at $40,000.

Theratechnologies Stock Up 0.3%

Shares of THTX stock traded up $0.01 during mid-day trading on Tuesday, reaching $3.15. 181,074 shares of the company's stock traded hands, compared to its average volume of 900,423. Theratechnologies Inc. has a 12 month low of $1.12 and a 12 month high of $3.20. The company has a market cap of $144.84 million, a P/E ratio of -16.58 and a beta of 0.55. The company's 50-day moving average price is $2.68 and its 200-day moving average price is $2.16.

Theratechnologies (NASDAQ:THTX - Get Free Report) last announced its earnings results on Wednesday, July 9th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.08). The firm had revenue of $17,729 billion for the quarter, compared to analysts' expectations of $24.30 million. Equities analysts predict that Theratechnologies Inc. will post 0.01 earnings per share for the current year.

Analyst Ratings Changes

Separately, Jones Trading cut shares of Theratechnologies from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 3rd.

Read Our Latest Stock Analysis on THTX

Theratechnologies Profile

(Free Report)

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.

Read More

Institutional Ownership by Quarter for Theratechnologies (NASDAQ:THTX)

Should You Invest $1,000 in Theratechnologies Right Now?

Before you consider Theratechnologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.

While Theratechnologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AI Stocks Are Printing Money — These 3 Are Just Getting Started
Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines